Double Strand Break Repair, one mechanism can hide another: Alternative non-homologous end joining;Réparation des cassures double-brin de l'ADN, un mécanisme peut en cacher un autre: La ligature d'extrémités non homologues alternative

Cancer/Radiotherapie

Volumn 16, Issue 1, 2012, Pages 1-10

  Rass, E ^a,b   Grabarz, A ^a,b   Bertrand, P ^a,b   Lopez, B S ^a,b  

^a CNRS   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

DNA double strand break repair; Genetic instability; Homologous recombination; Mutagenesis; NHEJ; Non homologous end joining

Indexed keywords

DNA; DOUBLE STRANDED DNA; KU ANTIGEN; LIGASE; SINGLE STRANDED DNA;

DNA END JOINING REPAIR; DNA RECOMBINATION; DNA REPAIR; DNA SEQUENCE; DOUBLE STRANDED DNA BREAK; GENE DELETION; IONIZING RADIATION; PRIORITY JOURNAL; SHORT SURVEY; STRUCTURAL HOMOLOGY;

DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; DNA REPAIR; DNA, SINGLE-STRANDED; GENOMIC INSTABILITY; HUMANS; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 84857457722     PISSN: 12783218     EISSN: 17696658     Source Type: Journal    
DOI: 10.1016/j.canrad.2011.05.004     Document Type: Short Survey

References (68)

1. Jackson S.P., Bartek J. The DNA-damage response in human biology and disease. Nature. 2009, 461:1071-1078.
2. Plo I., Laulier C., Gauthier L., Lebrun F., Calvo F., Lopez B.S. AKT1 inhibits homologous recombination by inducing cytoplasmic retention of BRCA1 and RAD51. Cancer Res. 2008, 68:9404-9412.
3. Laulier C., Barascu A., Guirouilh-Barbat J., Pennarun G., Le Chalony C., Chevalier F., et al. Bcl-2 Inhibits Nuclear Homologous Recombination by Localizing BRCA1 to the Endomembranes. Cancer Res. 2011, 71:3590-3602.
4. Saintigny Y., Delacote F., Vares G., Petitot F., Lambert S., Averbeck D., et al. Characterization of homologous recombination induced by replication inhibition in mammalian cells. Embo J. 2001, 20:3861-3870.
5. Hyrien O. Mechanisms and consequences of replication fork arrest. Biochimie. 2000, 82:5-17.
6. Bartkova J., Horejsi Z., Koed K., Kramer A., Tort F., Zieger K., et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005, 434:864-870.
7. Gorgoulis V.G., Vassiliou L.V., Karakaidos P., Zacharatos P., Kotsinas A., Liloglou T., et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature. 2005, 434:907-913.
8. Mimitou E.P., Symington L.S. DNA end resection: many nucleases make light work. DNA Repair (Amst). 2009, 8:983-995.
9. Huertas P. DNA resection in eukaryotes: deciding how to fix the break. Nat Struct Mol Biol. 2010, 17:11-16.
10. Bouwman P., Aly A., Escandell J.M., Pieterse M., Bartkova J., van der Gulden H., et al. 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nat Struct Mol Biol. 2010, 17:688-895.
11. Bunting S.F., Callen E., Wong N., Chen H.T., Polato F., Gunn A., et al. 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell. 2010, 141:243-254.
12. Cao L., Xu X., Bunting S.F., Liu J., Wang R.H., Cao L.L., et al. A selective requirement for 53BP1 in the biological response to genomic instability induced by Brca1 deficiency. Mol Cell. 2009, 35:534-541.
13. Bolderson E., Tomimatsu N., Richard D.J., Boucher D., Kumar R., Pandita T.K., et al. Phosphorylation of Exo1 modulates homologous recombination repair of DNA double-strand breaks. Nucleic Acids Res. 2010, 38:1821-1831.
14. Eid W., Steger M., El-Shemerly M., Ferretti L.P., Pena-Diaz J., Konig C., et al. DNA end resection by CtIP and exonuclease 1 prevents genomic instability. EMBO Rep. 2010, 11:962-968.
15. Gravel S., Chapman J.R., Magill C., Jackson S.P. DNA helicases Sgs1 and BLM promote DNA double-strand break resection. Genes Dev. 2008, 22:2767-2772.
16. Nimonkar A.V., Ozsoy A.Z., Genschel J., Modrich P., Kowalczykowski S.C. Human exonuclease 1 and BLM helicase interact to resect DNA and initiate DNA repair. Proc Natl Acad Sci U S A. 2008, 105:16906-16911.
17. Nimonkar A.V., Genschel J., Kinoshita E., Polaczek P., Campbell J.L., Wyman C., et al. BLM-DNA2-RPA-MRN and EXO1-BLM-RPA-MRN constitute two DNA end resection machineries for human DNA break repair. Genes Dev. 2011, 25:350-362.
18. Liang F., Jasin M. Ku80-deficient cells exhibit excess degradation of extrachromosomal DNA. J Biol Chem. 1996, 271:14405-14411.
19. Feldmann E., Schmiemann V., Goedecke W., Reichenberger S., Pfeiffer P. DNA double-strand break repair in cell-free extracts from Ku80-deficient cells: implications for Ku serving as an alignment factor in non-homologous DNA end joining. Nucleic Acids Res. 2000, 28:2585-2596.
20. Kabotyanski E.B., Gomelsky L., Han J.O., Stamato T.D., Roth D.B. Double-strand break repair in Ku86- and XRCC4-deficient cells. Nucleic Acids Res. 1998, 26:5333-5342.
21. Gottlich B., Reichenberger S., Feldmann E., Pfeiffer P. Rejoining of DNA double-strand breaks in vitro by single-strand annealing. Eur J Biochem. 1998, 258:387-395.
22. Boulton S.J., Jackson S.P. Saccharomyces cerevisiae Ku70 potentiates illegitimate DNA double-strand break repair and serves as a barrier to error-prone DNA repair pathways. EMBO J. 1996, 15:5093-5103.
23. Audebert M., Salles B., Calsou P. Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J Biol Chem. 2004, 279:55117-55126.
24. DiBiase S.J., Zeng Z.C., Chen R., Hyslop T., Curran W.J., Iliakis G. DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus. Cancer Res. 2000, 60:1245-1253.
25. Perrault R., Wang H., Wang M., Rosidi B., Iliakis G. Backup pathways of NHEJ are suppressed by DNA-PK. J Cell Biochem. 2004, 92:781-794.
26. Bennardo N., Cheng A., Huang N., Stark J.M. Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair. PLoS Genet. 2008, 4:e1000110.
27. Liang L., Deng L., Chen Y., Li G.C., Shao C., Tischfield J.A. Modulation of DNA end joining by nuclear proteins. J Biol Chem. 2005, 280:31442-31449.
28. Wang M., Wu W., Wu W., Rosidi B., Zhang L., Wang H., et al. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways. Nucleic Acids Res. 2006, 34:6170-6182.
29. Ma J.L., Kim E.M., Haber J.E., Lee S.E. Yeast Mre11 and Rad1 proteins define a Ku-independent mechanism to repair double-strand breaks lacking overlapping end sequences. Mol Cell Biol. 2003, 23:8820-8828.
30. Guirouilh-Barbat J., Huck S., Bertrand P., Pirzio L., Desmaze C., Sabatier L., et al. Impact of the KU80 Pathway on NHEJ-Induced Genome Rearrangements in Mammalian Cells. Mol Cell. 2004, 14:611-623.
31. Guirouilh-Barbat J., Rass E., Plo I., Bertrand P., Lopez B.S., Defects in XRCC4, et al. Defects in XRCC4 and KU80 differentially affect the joining of distal nonhomologous ends. Proc Natl Acad Sci U S A 2007, 104:20902-20907.
32. Schulte-Uentrop L., El-Awady R.A., Schliecker L., Willers H., Dahm-Daphi J. Distinct roles of XRCC4 and Ku80 in non-homologous end-joining of endonuclease- and ionizing radiation-induced DNA double-strand breaks. Nucleic Acids Res. 2008, 36:2561-2569.
33. Decottignies A. Microhomology-mediated end joining in fission yeast is repressed by pku70 and relies on genes involved in homologous recombination. Genetics. 2007, 176:1403-14015.
34. Lee K., Lee S.E. Saccharomyces cerevisiae Sae2- and Tel1-dependent single-strand DNA formation at DNA break promotes microhomology-mediated end joining. Genetics. 2007, 176:2003-2014.
35. Guirouilh-Barbat J., Huck S., Lopez B.S. S-phase progression stimulates both the mutagenic KU-independent pathway and mutagenic processing of KU-dependent intermediates, for nonhomologous end joining. Oncogene. 2008, 27:1726-1736.
36. Yan C.T., Boboila C., Souza E.K., Franco S., Hickernell T.R., Murphy M., et al. IgH class switching and translocations use a robust non-classical end-joining pathway. Nature. 2007, 449:478-482.
37. Soulas-Sprauel P., Le Guyader G., Rivera-Munoz P., Abramowski V., Olivier-Martin C., Goujet-Zalc C., et al. Role for DNA repair factor XRCC4 in immunoglobulin class switch recombination. J Exp Med. 2007, 204:1717-1727.
38. Corneo B., Wendland R.L., Deriano L., Cui X., Klein I.A., Wong S.Y., et al. Rag mutations reveal robust alternative end joining. Nature. 2007, 449:483-486.
39. Chayot R., Montagne B., Mazel D., Ricchetti M. An end-joining repair mechanism in Escherichia coli. Proc Natl Acad Sci U S A 2010, 107:2141-2146.
40. Wang H., Rosidi B., Perrault R., Wang M., Zhang L., Windhofer F., et al. DNA ligase III as a candidate component of backup pathways of nonhomologous end joining. Cancer Res. 2005, 65:4020-4030.
41. Audebert M., Salles B., Calsou P. Effect of double-strand break DNA sequence on the PARP-1 NHEJ pathway. Biochem Biophys Res Commun. 2008, 369:982-988.
42. Robert I., Dantzer F., Reina-San-Martin B. Parp1 facilitates alternative NHEJ, whereas Parp2 suppresses IgH/c-myc translocations during immunoglobulin class switch recombination. J Exp Med. 2009, 206:1047-1056.
43. Verkaik N.S., Esveldt-van Lange R.E., van Heemst D., Bruggenwirth H.T., Hoeijmakers J.H., Zdzienicka M.Z., et al. Different types of V(D)J recombination and end-joining defects in DNA double-strand break repair mutant mammalian cells. Eur J Immunol. 2002, 32:701-709.
44. Buis J., Wu Y., Deng Y., Leddon J., Westfield G., Eckersdorff M., et al. Mre11 nuclease activity has essential roles in DNA repair and genomic stability distinct from ATM activation. Cell. 2008, 135:85-96.
45. Rass E., Grabarz A., Plo I., Gautier J., Bertrand P., Lopez B.S. Role of Mre11 in chromosomal non-homologous end joining in mammalian cells. Nat Struct Mol Biol. 2009, 16:819-824.
46. Dinkelmann M., Spehalski E., Stoneham T., Buis J., Wu Y., Sekiguchi J.M., et al. Multiple functions of MRN in end-joining pathways during isotype class switching. Nat Struct Mol Biol. 2009, 16:808-813.
47. Xie A., Kwok A., Scully R. Role of mammalian Mre11 in classical and alternative non-homologous end joining. Nat Struct Mol Biol. 2009, 16:814-818.
48. Zhuang J., Jiang G., Willers H., Xia F. Exonuclease function of human Mre11 promotes deletional non-homologous end joining. J Biol Chem. 2009, 284:30565-30573.
49. Weinstock D.M., Brunet E., Jasin M. Formation of NHEJ-derived reciprocal chromosomal translocations does not require Ku70. Nat Cell Biol. 2007, 9:978-981.
50. Boboila C., Jankovic M., Yan C.T., Wang J.H., Wesemann D.R., Zhang T., et al. Alternative end-joining catalyzes robust IgH locus deletions and translocations in the combined absence of ligase 4 and Ku70. Proc Natl Acad Sci U S A 2010, 107:3034-3039.
51. Simsek D., Jasin M. Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation. Nat Struct Mol Biol. 2010, 17:410-416.
52. Stephens P.J., McBride D.J., Lin M.L., Varela I., Pleasance E.D., Simpson J.T., et al. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature. 2009, 462:1005-1010.
53. Burdak-Rothkamm S., Prise K.M. New molecular targets in radiotherapy: DNA damage signalling and repair in targeted and non-targeted cells. Eur J Pharmacol. 2009, 625:151-155.
54. Price M., Monteiro A.N. Fine tuning chemotherapy to match BRCA1 status. Biochem Pharmacol. 2010, 80:647-653.
55. Bolderson E., Richard D.J., Zhou B.B., Khanna K.K. Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair. Clin Cancer Res. 2009, 15:6314-6320.
56. Vogin G. Radiosensibilité, radiocurabilité et réparation. Cancer Radiother 2011, 10.1016/j.canrad.2010.10.004.
57. Deriano L., Guipaud O., Merle-Beral H., Binet J.L., Ricoul M., Potocki-Veronese G., et al. Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway. Blood. 2005, 105:4776-4783.
58. Mukherjee B., Choy H., Nirodi C., Burma S. Targeting nonhomologous end-joining through epidermal growth factor receptor inhibition: rationale and strategies for radiosensitization. Semin Radiat Oncol. 2010, 20:250-257.
59. Facchino S., Abdouh M., Chatoo W., Bernier G. BMI1 confers radioresistance to normal and cancerous neural stem cells through recruitment of the DNA damage response machinery. J Neurosci. 2010, 30:10096-10111.
60. Farmer H., McCabe N., Lord C.J., Tutt A.N., Johnson D.A., Richardson T.B., et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature. 2005, 434:917-921.
61. Bryant H.E., Schultz N., Thomas H.D., Parker K.M., Flower D., Lopez E., et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature. 2005, 434:913-917.
62. Underhill C., Toulmonde M., Bonnefoi H. A review of PARP inhibitors: from bench to bedside. Ann Oncol. 2011, 22:268-279.
63. Leung M., Rosen D., Fields S., Cesano A., Budman D.R. Poly (ADP-ribose) polymerase-1 Inhibition: preclinical and clinical development of synthetic lethality. Mol Med 2011, 10.2119/molmed.2010.00240.
64. Veuger S.J., Curtin N.J., Richardson C.J., Smith G.C., Durkacz B.W. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1. Cancer Res. 2003, 63:6008-6015.
65. Loser D.A., Shibata A., Shibata A.K., Woodbine L.J., Jeggo P.A., Chalmers A.J. Sensitization to radiation and alkylating agents by inhibitors of poly(ADP-ribose) polymerase is enhanced in cells deficient in DNA double-strand break repair. Mol Cancer Ther. 2010, 9:1775-1787.
66. Cariveau M.J., Tang X., Cui X.L., Xu B. Characterization of an NBS1 C-terminal peptide that can inhibit ataxia telangiectasia mutated (ATM)-mediated DNA damage responses and enhance radiosensitivity. Mol Pharmacol. 2007, 72:320-326.
67. Dupre A., Boyer-Chatenet L., Sattler R.M., Modi A.P., Lee J.H., Nicolette M.L., et al. A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex. Nat Chem Biol. 2008, 4:119-125.
68. Fan J, Li L, Small D and Rassool F. Cells expressing FLT3/ITD mutations exhibit elevated repair errors generated through alternative NHEJ pathways: implications for genomic instability and Therapy. Blood 2010;9:5298-305.